How is the stem cell and regenerative medicine biotech sector doing these days and does recent news about specific biotechs such as Capricor suggest issues for the sector more broadly? Capricor had bad news earlier this year related to its [...]
The post Shot to the heart: J&J punts on Capricor & its cardiac stem cell program appeared first on The Niche.
